RANBP17: A Potential Drug Target and Biomarker (G64901)

Target Name: RANBP17

NCBI ID: G64901

RANBP17

Other Name(s): RAN binding protein 17 | FLJ32916 | RBP17_HUMAN | Ran-binding protein 17

RANBP17: A Potential Drug Target and Biomarker

RanBP17, also known as RAN binding protein 17, is a protein that is expressed in various tissues and cell types in the human body. It plays a critical role in cell signaling and is involved in the regulation of various cellular processes. Several studies have suggested that RANBP17 may have potential as a drug target or biomarker, making it an attractive target for researchers to investigate further.

The RANBP17 gene was identified in the database as having potential for developing new therapeutics for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The protein itself has been shown to play a role in several cellular processes, including cell signaling, cell division, and inflammation.

One of the key functions of RANBP17 is its role in the regulation of the RhoA GTPase. RhoA is a protein that plays a critical role in cell signaling and is involved in the regulation of various cellular processes. GTPase is a type of protein that uses the energy from GTP to regulate the movement of molecules, including proteins. RANBP17 has been shown to interact with RhoA and regulate its activity.

Several studies have suggested that RANBP17 may be a potential drug target or biomarker by inhibiting the activity of RhoA. This would result in the inhibition of cell signaling and potentially lead to the collapse of cellular processes that contribute to the development of various diseases.

Another potential function of RANBP17 is its role in cell division. RANBP17 has been shown to play a role in the regulation of cell division and has been shown to interact with the protein p21. p21 is a tumor suppressor protein that plays a critical role in cell division and has been shown to be involved in the regulation of apoptosis, which is the process of cell death.

In addition to its role in cell signaling and cell division, RANBP17 has also been shown to play a role in inflammation. RANBP17 has been shown to interact with the protein NF-kappa-B and has been shown to contribute to the regulation of inflammation.

The potential drug targets for RANBP17 are vast, and include the regulation of cell signaling, cell division, and inflammation. These potential targets make RANBP17 an attractive target for researchers to investigate further, in order to develop new therapeutics for various diseases.

In conclusion, RANBP17 is a protein that has been shown to play a critical role in several cellular processes, including cell signaling, cell division, and inflammation. Its potential as a drug target or biomarker makes it an attractive target for researchers to investigate further, in order to develop new therapeutics for various diseases. Further studies are needed to fully understand the role of RANBP17 in cellular processes and its potential as a drug target or biomarker.

Protein Name: RAN Binding Protein 17

Functions: May function as a nuclear transport receptor

The "RANBP17 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RANBP17 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets